Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3055% below fair value
$4.62−0.21 (-4.35%)
Close on Nov 17, 2026Market cap $522.33MP/E –Yield –
Evolent Health pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Evolent Health's pe ratio was 3.7× on Jul 29, 2016.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2016 | Jul 29, 2016 | 3.7× | −10.6 |
| 2015 | Dec 31, 2015 | 14.2× | – |
See a number that looks wrong?